Journal of diabetes and metabolic disorders
Mar 7, 2024
PURPOSE: Advanced hybrid closed loop (AHCL) systems have the potential to improve glycemia and reduce burden for people with type 1 diabetes (T1D). Children and youth, who are at particular risk for out-of-target glycemia, may have the most to gain f...
Journal of diabetes and metabolic disorders
Dec 5, 2023
PURPOSE: Diabetes is a major public health challenge with widespread prevalence, often leading to complications such as Diabetic Nephropathy (DN)-a chronic condition that progressively impairs kidney function. In this context, it is important to eval...
Journal of diabetes and metabolic disorders
Nov 27, 2023
PURPOSE: We applied machine learning to study associations between regional body fat distribution and diabetes mellitus in a population of community adults in order to investigate the predictive capability. We retrospectively analyzed a subset of dat...
Journal of diabetes and metabolic disorders
Nov 22, 2023
OBJECTIVES: Diabetes has become a leading cause of mortality in both developed and developing countries, impacting a growing number of individuals worldwide. As the prevalence of the disease continues to rise, researchers have diligently worked towar...
Journal of diabetes and metabolic disorders
Oct 27, 2023
OBJECTIVE: The objective of this scoping review was to investigate the effectiveness and limitations of risk prediction models for postpartum glucose intolerance in women with gestational diabetes mellitus (GDM). The aim was to provide valuable insig...
Journal of diabetes and metabolic disorders
Nov 24, 2021
It has been well established that understanding the underlying heterogeneity of numerous complex disease process needs new strategies that present in precision medicine for prediction, prevention and personalized treatment strategies. This approach m...
Journal of diabetes and metabolic disorders
Oct 1, 2018
OBJECTIVE: To evaluate the basal/total ratio of daily insulin dose (b/T) in outpatients with diabetes type 1 (DM1) and type 2 (DM2) on basal-bolus regimen, by investigating whether there is a relationship with HbA1c and episodes of hypoglycemia.
Journal of diabetes and metabolic disorders
Sep 29, 2016
BACKGROUND: Chronic inflammation is a hallmark of type-2 diabetes (T2D) and asthma. Monocyte chemoattractant protein (MCP)-1 or CCL-2 is a key regulator of monocytic infiltration into the sites of inflammation. The changes in systemic MCP-1 levels an...